IFNA1 and COVID-19: We stimulated healthy donor peripheral blood mononuclear cells (PBMCs) with various IFNs, cytokines and Toll-like receptor (TLR) agonists and with plasma or serum collected from patients with different IFN-driven diseases, including JDM, adult DM, JSLE and COVID-19.